Rapid Micro Biosystems (RPID) Enterprise Value (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Enterprise Value of -$9.4 million for Q1 2026, up 58.74% on a YoY basis from -$5.9 million in Q1 2025, and up 48.63% sequentially from -$18.4 million in Q4 2025.
Rapid Micro Biosystems (RPID) Enterprise Value (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Enterprise Value data on file, last reported at -$9.4 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 58.74% year-over-year to -$9.4 million; the trailing twelve-month figure through Mar 2026 stood at -$9.4 million (up 58.74% YoY), and the FY2025 full-year result was -$18.4 million, up 63.8% from the prior year.
- Enterprise Value climbed to -$9.4 million in Q1 2026, from -$18.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$9.4 million in Q1 2026 to a low of -$162.2 million in Q1 2022.
- A 5-year average of -$67.0 million and a median of -$60.8 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value sank 430.72% in 2022 and jumped 63.8% in 2025, its largest moves.
- Tracing RPID's Enterprise Value over 5 years: stood at -$81.8 million in 2022, then increased by 17.02% to -$67.9 million in 2023, then increased by 25.25% to -$50.7 million in 2024, then jumped by 63.8% to -$18.4 million in 2025, then jumped by 48.63% to -$9.4 million in 2026.
- Business Quant data shows RPID's Enterprise Value at -$9.4 million in Q1 2026, -$18.4 million in Q4 2025, and -$41.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | -9.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.43 Mn |
| Dec 31, 2025 | -18.37 Mn |
| Sep 30, 2025 | -41.25 Mn |
| Jun 30, 2025 | -31.26 Mn |
| Mar 31, 2025 | -22.86 Mn |
| Dec 31, 2024 | -50.73 Mn |
| Sep 30, 2024 | -60.83 Mn |
| Jun 30, 2024 | -32.37 Mn |
| Mar 31, 2024 | -57.20 Mn |
| Dec 31, 2023 | -67.87 Mn |
| Sep 30, 2023 | -65.90 Mn |
| Jun 30, 2023 | -77.59 Mn |
| Mar 31, 2023 | -99.69 Mn |
| Dec 31, 2022 | -81.78 Mn |
| Sep 30, 2022 | -114.89 Mn |
| Jun 30, 2022 | -144.09 Mn |
| Mar 31, 2022 | -162.23 Mn |
| Dec 31, 2021 | -15.41 Mn |
| Sep 30, 2021 | -219.59 Mn |
| Jun 30, 2021 | -101.32 Mn |